ask="1.30"
ask_size="5300"
average_daily_volume="616032"
bid="1.00"
bid_size="100"
book_value="0.52"
change="-0.01"
change_from_200_day_moving_average="0.15"
change_from_50_day_moving_average="0.05"
change_from_52_week_high="-1.06"
change_From_52_week_low="0.68"
change_in_percent="-0.83%"
close="1.19"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.24"
ebitda="-20.52M"
eps_estimate_current_year="-0.24"
eps_estimate_next_quarter="-0.07"
eps_estimate_next_year="-0.27"
ex_dividend_date="N/A"
float_shares="56757000"
high="1.21"
high_52_weeks="2.25"
last_trade_date="1/20/2017"
last_trade_price="1.19"
last_trade_size="1100"
last_trade_time="4:00pm"
low="1.16"
low_52_weeks="0.51"
market_capitalization="98.62M"
moving_average_200_day="1.04"
moving_average_50_day="1.14"
name="Catalyst Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="4.38"
open="1.19"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+14.82%"
percent_change_from_50_day_moving_average="+4.19%"
percent_change_from_52_week_high="-47.11%"
percent_change_from_52_week_low="+133.33%"
previous_close="1.20"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.32"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="82870000"
short_ratio="5.52"
stock_exchange="NCM"
symbol="CPRX"
volume="348657"
weeks_range_52="0.51 - 2.25"
